Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels

Testosterone treatment of men with low testosterone is common and, although relatively short-term, has raised concern regarding an increased risk of prostate cancer (CaP). We investigated the association between modest-duration testosterone treatment and incident aggressive CaP. Retrospective incept...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2018-06, Vol.13 (6), p.e0199194
Hauptverfasser:	Walsh, Thomas J, Shores, Molly M, Krakauer, Chloe A, Forsberg, Christopher W, Fox, Alexandra E, Moore, Kathryn P, Korpak, Anna, Heckbert, Susan R, Zeliadt, Steven B, Kinsey, Chloe E, Thompson, Mary Lou, Smith, Nicholas L, Matsumoto, Alvin M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Androgens Antigens Biology and Life Sciences Biopsy Body mass Breast cancer Cancer Care and treatment Clinical trials Development and progression Geography Geriatrics Health aspects Health care Health risks Hormone replacement therapy Hormone Replacement Therapy - adverse effects Hormone Replacement Therapy - methods Humans Hypogonadism - blood Hypogonadism - drug therapy Incidence Kallikreins - blood Male Medical diagnosis Medical research Medical screening Medicine and Health Sciences Men Middle Aged Prostate - pathology Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology Retrospective Studies Risk Studies Systematic review Testosterone Testosterone - adverse effects Testosterone - blood Testosterone - deficiency United States - epidemiology United States Department of Veterans Affairs - statistics & numerical data Veterans Veterans - statistics & numerical data
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!